Literature DB >> 25605448

Large-scale in vitro expansion of human regulatory T cells with potent xenoantigen-specific suppression.

Xi Jin1,2,3, Yanrong Lu1,2, Ye Zhao3, Shounan Yi4,5.   

Abstract

Xenotransplantation is a potential solution to the organ donor shortage. Immunosuppression is required for successful application of xenotransplantation but may lead to infection and cancer. Thus, strategies for immune tolerance induction need to be developed. Polyclonal regulatory T cells (Treg) play a central role in the induction and maintenance of immune tolerance and have been shown to protect against islet xenograft rejection in vivo. However, global immune suppression may be mediated by polyclonal Treg immunotherapy and a simple method for in vitro expansion of xenoantigen-specific Treg for efficient Treg application becomes necessary. Human Treg isolated from peripheral blood mononuclear cells (PBMCs) were initially cultured with anti-CD3/CD28 beads, rapamycin and IL-2 for 7 days as polyclonal expansion. Expanded Treg were then cocultured with irradiated porcine PBMC as xenoantigen stimulation for three subsequent cycles with 7 days for each cycle in the presence of IL-2 and anti-CD3/CD28 beads. Treg phenotype and suppressive capacity were assessed after each cycle of xenoantigen stimulation. Treg expanded with one cycle of xenoantigen stimulation retained Treg suppressive phenotype but acquired no xenoantigen specificity along with poor expansion efficiency, whereas expansion with two-cycle xenoantigen stimulation resulted in not only more than 800-fold Treg expansion but highly suppressive xenoantigen-specific Treg with effector Treg phenotype. However further increase of stimulation cycles resulted in reduced Treg suppressive potency. This study provides a simple approach to obtain high numbers of xenoantigen-specific Treg for immune tolerance induction in xenotransplantation.

Entities:  

Keywords:  In vitro expansion; Regulatory T cells; Xenoantigen-specificity; Xenotransplantation

Year:  2015        PMID: 25605448      PMCID: PMC4960143          DOI: 10.1007/s10616-015-9845-1

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  40 in total

1.  Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells.

Authors:  Xuguang Tai; François Van Laethem; Leonid Pobezinsky; Terry Guinter; Susan O Sharrow; Anthony Adams; Larry Granger; Michael Kruhlak; Tullia Lindsten; Craig B Thompson; Lionel Feigenbaum; Alfred Singer
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

2.  In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.

Authors:  Dela Golshayan; Shuiping Jiang; Julia Tsang; Marina I Garin; Christian Mottet; Robert I Lechler
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

3.  CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset.

Authors:  Markus Kleinewietfeld; Fabiola Puentes; Giovanna Borsellino; Luca Battistini; Olaf Rötzschke; Kirsten Falk
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

Review 4.  Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential.

Authors:  Emma L Masteller; Qizhi Tang; Jeffrey A Bluestone
Journal:  Semin Immunol       Date:  2006-02-03       Impact factor: 11.130

5.  Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease.

Authors:  Xiaofeng Qian; Ke Wang; Xuehao Wang; Song Guo Zheng; Ling Lu
Journal:  Int Immunopharmacol       Date:  2010-12-13       Impact factor: 4.932

6.  Rapid assessment of in vitro expanded human regulatory T cell function.

Authors:  Joyce J Ruitenberg; Christopher Boyce; Ravi Hingorani; Amy Putnam; Smita A Ghanekar
Journal:  J Immunol Methods       Date:  2011-07-18       Impact factor: 2.303

7.  In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses.

Authors:  Jingjing Wu; Shounan Yi; Li Ouyang; Elvira Jimenez; Denbigh Simond; Wei Wang; Yiping Wang; Wayne J Hawthorne; Philip J O'Connell
Journal:  Transplantation       Date:  2008-06-27       Impact factor: 4.939

8.  Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells.

Authors:  Pervinder Sagoo; Niwa Ali; Garima Garg; Frank O Nestle; Robert I Lechler; Giovanna Lombardi
Journal:  Sci Transl Med       Date:  2011-05-18       Impact factor: 17.956

9.  DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients.

Authors:  Matthias Schaier; Nicole Seissler; Edgar Schmitt; Stefan Meuer; Friederike Hug; Martin Zeier; Andrea Steinborn
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

10.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  4 in total

1.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

2.  A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35.

Authors:  Mingqian Li; Judith Eckl; Christiane Geiger; Dolores J Schendel; Heike Pohla
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

Review 3.  Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune Dysregulation.

Authors:  Otavio Cabral-Marques; Lena F Schimke; Edgar Borges de Oliveira; Nadia El Khawanky; Rodrigo Nalio Ramos; Basel K Al-Ramadi; Gesmar Rodrigues Silva Segundo; Hans D Ochs; Antonio Condino-Neto
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

4.  Hepatitis C Virus Improves Human Tregs Suppressive Function and Promotes Their Recruitment to the Liver.

Authors:  Laurissa Ouaguia; Olivier Moralès; Lynda Aoudjehane; Czeslaw Wychowski; Abhishek Kumar; Jean Dubuisson; Yvon Calmus; Filomena Conti; Nadira Delhem
Journal:  Cells       Date:  2019-10-22       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.